HealthcareServices

Global Cholestatic Pruritus Industry Trends: Where the Market Is Headed by 2029

November 27, 2025 by Marketing Posting

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

How Much Was The Cholestatic Pruritus Market Worth In 2025, And What Is Its Anticipated Value By 2029?

The market for cholestatic pruritus has experienced substantial expansion in recent years. Its value is projected to climb from $19.2 billion in 2024 to $20.22 billion in 2025, achieving a compound annual growth rate (CAGR) of 5.3%. This historical development can be attributed to an uptick in the prevalence of skin disorders, increased funding in research and development, a strong need for effective treatments, heightened awareness of the condition, and advantageous regulatory environments.

The cholestatic pruritus market size is projected to experience substantial growth over the coming years, anticipated to reach $24.78 billion by 2029, expanding at a compound annual growth rate (CAGR) of 5.2%. This growth throughout the forecast period is primarily due to the expanding elderly demographic, the rising incidence of atopic dermatitis and urticaria, an increase in chronic kidney diseases, and the growing prevalence of conditions linked to pruritus. Key trends expected in this period encompass the development of novel treatment options, strategic collaborations with major corporations for cholestasis pruritus research, advancements in treatment approaches, the enlargement of healthcare infrastructure, and technological progress.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=21140&type=smp

Which Industry Drivers Are Expected To Accelerate The Cholestatic Pruritus Market From 2025 To 2029?

The rising occurrence of liver conditions is anticipated to fuel the expansion of the cholestatic pruritus market in the future. Liver diseases encompass a wide variety of ailments impacting liver functionality, such as infections, autoimmune conditions, inherited disorders, and toxin-induced harm, which can result in inflammation, fibrosis, or hepatic failure. The escalating incidence of liver ailments is driven by rising rates of obesity, diabetes, alcohol consumption, viral hepatitis infections, and contact with toxins and environmental elements. Cholestatic pruritus plays a role in detecting and managing liver diseases by acting as a significant indicator of compromised bile flow, frequently leading to deeper examination and therapy for the underlying liver problems. As an illustration, in July 2023, the Office for Health Improvement and Disparities, a UK-based government body dedicated to tackling health disparities, reported that hospital admissions for liver disease in England saw a 22% increase in the year ending 2022, climbing from 67,458 to 82,290. Consequently, the growing frequency of liver diseases will stimulate the development of the cholestatic pruritus market.

What Are The Key Segments In The Cholestatic Pruritus Market?

The cholestatic pruritusmarket covered in this report is segmented –

1) By Disease Type: Primary Biliary Cholangitis (PBC); Primary Sclerosing Cholangitis (PSC); Intrahepatic Cholestasis of Pregnancy (ICP); Other Disease Types

2) By Treatment Type: Medications; Phototherapy; Other Treatment Types

3) By Route Of Administration: Oral; Topical; Injectable

4) By End-User: Hospitals; Clinics; Ambulatory Care Centers; Homecare

Subsegments:

1) By Primary Biliary Cholangitis (PBC): Early-Stage PBC; Advanced PBC; PBC With Cirrhosis; PBC With Liver Failure

2) By Primary Sclerosing Cholangitis (PSC): Classic PSC; PSC With Ulcerative Colitis; PSC With Bile Duct Strictures

3) By Intrahepatic Cholestasis of Pregnancy (ICP): Mild ICP; Severe ICP; ICP With Preterm Birth Risk

4) By Other Disease Types: Alcoholic Cholestasis; Drug-Induced Cholestasis; Viral Hepatitis-Induced Cholestasis; Genetic Cholestasis Disorders

How Are Emerging Market Trends Shaping The Cholestatic Pruritus Industry Landscape?

Major companies operating in the cholestatic pruritus market are actively developing innovative solutions, including oral solutions, to manage symptoms more effectively, improve patient compliance, and provide targeted relief by addressing the underlying causes of bile salt accumulation and inflammation. An oral solution for the treatment of cholestatic pruritus is defined as a liquid formulation of medication crafted to reduce bile acid accumulation and alleviate severe itching in patients with cholestasis. As an illustration, in March 2024, Mirum Pharmaceuticals Inc., a US-based biopharmaceutical company, secured approval from the U.S. Food and Drug Administration (FDA) for LIVMARLI (maralixibat) oral solution, intended for treating cholestatic pruritus in patients aged five and older with progressive familial intrahepatic cholestasis (PFIC). This once-daily, orally administered ileal bile acid transporter inhibitor possesses a breakthrough therapy designation for PFIC type 2. LIVMARLI is set to significantly benefit patients with cholestatic pruritus linked to PFIC, providing a crucial treatment option for individuals with the rarest subtypes.

Who Are The Primary Competitors In The Global Cholestatic Pruritus Market?

Major companies operating in the cholestatic pruritus market are GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Merck KGaA, Regeneron Pharmaceuticals Inc., Bausch Health Companies Inc., Incyte Corporation, Ipsen Pharma, Vanda Pharmaceuticals Inc., Medison Pharma Ltd., Mirum Pharmaceuticals Inc., Albireo Pharma Inc., Dipharma Francis S.r.l., Cara Therapeutics Inc., CANbridge Pharmaceuticals Inc., Escient Pharmaceuticals Inc., Tharimmune Inc., Vifor Fresenius Medical Care Renal Pharma, CymaBay Therapeutics Inc., ICE Pharma Inc., Aquatic Remedies Private Limited.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/cholestatic-pruritus-global-market-report

Which Regional Markets Are Contributing Most To The Cholestatic Pruritus Industry Expansion?

North America was the largest region in the cholestatic pruritus market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cholestatic pruritus market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Cholestatic Pruritus Market Report:

https://www.thebusinessresearchcompany.com/customise?id=21140&type=smp

Browse Through More Reports Similar to the Global Cholestatic Pruritus Market 2025, By The Business Research Company

Pruritus Therapeutic Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/pruritus-therapeutic-global-market-report

Pruritus Therapeutics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/pruritus-therapeutics-global-market-report

Primary Biliary Cholangitis Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/primary-biliary-cholangitis-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795